Postmenopausal estrogen use among African American and white patients at an urban clinic

Journal of Women's Health

Volumn 6, Issue 1, 1997, Pages 93-101

  Jahnige, Katherine ^a   Fiebach, Nicholas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CAUCASIAN; CORONARY RISK; EDUCATION; ESTROGEN THERAPY; ETHNIC GROUP; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RACE; UNITED STATES; URBAN AREA;

EID: 0030970050     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1997.6.93     Document Type: Article

References (22)

1. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992;117:1038.
2. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016.
3. Belchetz P. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062.
4. Consensus Conference: Osteoporosis. JAMA 1984;252:799.
5. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178.
6. Heaney RP. Estrogens and postmenopausal osteoporosis. Clin Obstet Gynecol 1976;19:791.
7. Lafferty FW, Helmuth DO. Post-menopausal estrogen replacement: The prevention of osteoporosis and systemic effects. Maturitas 1985;7:147.
8. Marsh MS, Whitehead MI. Management of the menopause. Br Med Bull 1992;48:426.
9. Reeve J. Future prospects for hormone replacement therapy. Br Med Bull 192;48:458.
10. Wilson JD, Foster DW, eds. Williams textbook of endocrinology. Philadelphia: W.B. Saunders Company, 1985.
11. Rodin J, Ickovics J. Women's health: Review and research agenda as we approach the 21st century. Am Psychol 1990;45:1018.
12. Wenger N. Coronary disease in women. Annu Rev Med 1985;36:285.
13. Miles TP, Malik KC. Menopause and African-American women: Clinical and research issues. Exp Gerontol 1994;29:511.
14. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403.
15. Nabulsi AN, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069.
16. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991;91:393.
17. Najjar MF, Rowland M. National Center for Health Statistics. Anthropometric reference data and prevalence of overweight, United States, 1976-1980. Vital and Health Statistics. Series 11. No. 238, Table 11, p. 22. DHHS Pub. No. (PHS) 87-1688. Public Health Service. Washington, DC: U.S. Government Printing Office, October 1987.
18. SAS/STAT user's guide, release 6.03 ed. Cary, NC: SAS Institute, Inc., 1988.
19. Seto TB, Taira DA, Dabis RB, Safran C, Phillips RS. Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 1996;11:197.
20. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993;137:1125.
21. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439.
22. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438.